Met Life Investment Management, LLC Immunome Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,265 shares of IMNM stock, worth $299,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,265
Previous 13,212
129.07%
Holding current value
$299,623
Previous $159,000
177.99%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$57 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$48.4 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$38.4 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$37.2 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$34.5 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $120M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...